Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
3
×
life sciences
national blog main
national top stories
new york
new york blog main
new york top stories
abbvie
acorda therapeutics
allergan
allosteric
ampyra
apokyn
apomorphine
atlas venture
atopic dermatitis
autoimmune disorders
biotech
boston
brace pharma
bristol-myers squibb
cleva pharma
clinical data
dalfampridine
deals
drug discovery
duopa
dupilumab
genfit
gilead sciences
glaxosmithkline
hotspot therapeutics
inbrija
intercept pharmaceuticals
investing
jonathan montagu
ldl-c
liver
What
disease
3
×
new
3
×
approved
drug
acorda
address
adds
ago
allosteric
clinic
cope
data
elusive
episodes
fatty
fda
friday
gets
help
horizon
hotspot
intercept
known
late
liver
looms
marketed
meant
medications
medicine
medicines
molecules
nash
nod
nonalcoholic
parkinson’s
path
patients
potential
rival
Language
unset
Current search:
disease
×
new
×
" clinical trials "
×
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
